| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.14 | 1e-05 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.16 | 2e-05 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.13 | 7e-05 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | -0.13 | 9e-05 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0001 |
| mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0005 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |